Showing results (441-450 of 472) with videos related to

Sort By:
Pageof 48
Journal of Hypertension|August 3, 2019
The association of smoothness index of central blood pressure with ambulatory carotid femoral pulse wave velocity after 20-week treatment with losartan in combination with amlodipine versus hydrochlorothiazideJinho Shin, Hae Young Lee, Wook Jin Chung, et al.
Nature Communications|October 31, 2014
Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patientsTae Jin Kim, Hyun-Tak Jin, Soo-Young Hur, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.
Clinical Therapeutics|March 25, 2019
Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind StudyTae-Seok Kim, Seung-Woon Rha, Seok-Yeon Kim, et al.
Clinical Therapeutics|June 3, 2018
Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary HypercholesterolemiaWoohyeun Kim, Yeonyee E Yoon, Sung-Hee Shin, et al.
Oncotarget|October 15, 2017
Is preoperative chronic kidney disease status associated with oncologic outcomes in upper urinary tract urothelial carcinoma? A multicenter propensity score-matched analysisHo Song Yu, Jun Eul Hwang, Ho Seok Chung, et al.
Clinical Hypertension|September 8, 2017
Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trialGyu Chul Oh, Hae-Young Lee, Wook Jin Chung, et al.
Clinical Therapeutics|February 7, 2018
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled TrialSoon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn, et al.
Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.
Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Pageof 48